FDA Drug Label · 2022

MOUNJARO (tirzepatide) injection, for subcutaneous use - Prescribing Information

Eli Lilly (2022). MOUNJARO (tirzepatide) injection, for subcutaneous use - Prescribing Information. FDA Drug Label.

FDA Drug Label

View original source
XRedditFacebook

Peptides linked in PeptIQ Wiki

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.